Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2000 1
2001 1
2002 2
2004 5
2005 3
2006 3
2007 4
2008 1
2009 2
2010 4
2011 6
2012 8
2013 12
2014 12
2015 16
2016 16
2017 8
2018 16
2019 17
2020 24
2021 32
2022 38
2023 44
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Results by year

Filters applied: . Clear all
Page 1
A review on therapeutic potential of Nigella sativa: A miracle herb.
Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, Damanhouri ZA, Anwar F. Ahmad A, et al. Asian Pac J Trop Biomed. 2013 May;3(5):337-52. doi: 10.1016/S2221-1691(13)60075-1. Asian Pac J Trop Biomed. 2013. PMID: 23646296 Free PMC article. Review.
Analysis of protein-coding genetic variation in 60,706 humans.
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O'Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, Tukiainen T, Birnbaum DP, Kosmicki JA, Duncan LE, Estrada K, Zhao F, Zou J, Pierce-Hoffman E, Berghout J, Cooper DN, Deflaux N, DePristo M, Do R, Flannick J, Fromer M, Gauthier L, Goldstein J, Gupta N, Howrigan D, Kiezun A, Kurki MI, Moonshine AL, Natarajan P, Orozco L, Peloso GM, Poplin R, Rivas MA, Ruano-Rubio V, Rose SA, Ruderfer DM, Shakir K, Stenson PD, Stevens C, Thomas BP, Tiao G, Tusie-Luna MT, Weisburd B, Won HH, Yu D, Altshuler DM, Ardissino D, Boehnke M, Danesh J, Donnelly S, Elosua R, Florez JC, Gabriel SB, Getz G, Glatt SJ, Hultman CM, Kathiresan S, Laakso M, McCarroll S, McCarthy MI, McGovern D, McPherson R, Neale BM, Palotie A, Purcell SM, Saleheen D, Scharf JM, Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT, Watkins HC, Wilson JG, Daly MJ, MacArthur DG; Exome Aggregation Consortium. Lek M, et al. Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057. Nature. 2016. PMID: 27535533 Free PMC article.
Access Cavity Preparations: Classification and Literature Review of Traditional and Minimally Invasive Endodontic Access Cavity Designs.
Shabbir J, Zehra T, Najmi N, Hasan A, Naz M, Piasecki L, Azim AA. Shabbir J, et al. J Endod. 2021 Aug;47(8):1229-1244. doi: 10.1016/j.joen.2021.05.007. Epub 2021 May 28. J Endod. 2021. PMID: 34058252 Review.
The rationale for this approach was derived from the assumption that preserving more tooth structure during access preparation will improve the tooth's resistance to fracture and its long-term survivability. However, is this assumption valid? ...
The rationale for this approach was derived from the assumption that preserving more tooth structure during access preparation will improve …
Therapeutic approaches of nutraceuticals in the prevention of Alzheimer's disease.
Pandey SN, Singh G, Semwal BC, Gupta G, Alharbi KS, Almalki WH, Albratty M, Najmi A, Meraya AM. Pandey SN, et al. J Food Biochem. 2022 Dec;46(12):e14426. doi: 10.1111/jfbc.14426. Epub 2022 Sep 28. J Food Biochem. 2022. PMID: 36169224 Review.
Alzheimer's disease (AD) is a neurological illness that causes memory loss over time. ...Given the potential of nutraceuticals to battle AD as multi-targeted therapies, it's vital to evaluate them as viable lead compounds for drug discovery and development. ...
Alzheimer's disease (AD) is a neurological illness that causes memory loss over time. ...Given the potential of nutraceuticals to bat …
Targeting hypercoagulation to alleviate Alzheimer's disease progression in metabolic syndrome.
Khan S, Pati S, Singh S, Akhtar M, Khare P, Khan S, Shafi S, Najmi AK. Khan S, et al. Int J Obes (Lond). 2022 Feb;46(2):245-254. doi: 10.1038/s41366-021-00977-1. Epub 2021 Oct 22. Int J Obes (Lond). 2022. PMID: 34686782 Review.
INTRODUCTION: Metabolic Syndrome (MetS) constitutes an important risk factor for Alzheimer's disease (AD); however, the mechanism linking these two disorders has not been completely elucidated. ...
INTRODUCTION: Metabolic Syndrome (MetS) constitutes an important risk factor for Alzheimer's disease (AD); however, the mechanism lin …
Understanding the Intricate Role of Exosomes in Pathogenesis of Alzheimer's Disease.
Chauhan S, Behl T, Sehgal A, Singh S, Sharma N, Gupta S, Albratty M, Najmi A, Meraya AM, Alhazmi HA. Chauhan S, et al. Neurotox Res. 2022 Dec;40(6):1758-1773. doi: 10.1007/s12640-022-00621-4. Epub 2022 Dec 24. Neurotox Res. 2022. PMID: 36564606 Review.
Alzheimer's disease causes loss of memory and deterioration of mental abilities is utmost predominant neurodegenerative disease accounting 70-80% cases of dementia. The appearance of plaques of amyloid-beta and neurofibrillary tangles in the brain post-mortems of Alzheimer …
Alzheimer's disease causes loss of memory and deterioration of mental abilities is utmost predominant neurodegenerative disease accou …
Understanding the role of "sunshine vitamin D" in Parkinson's disease: A review.
Behl T, Arora A, Singla RK, Sehgal A, Makeen HA, Albratty M, Meraya AM, Najmi A, Bungau SG. Behl T, et al. Front Pharmacol. 2022 Dec 19;13:993033. doi: 10.3389/fphar.2022.993033. eCollection 2022. Front Pharmacol. 2022. PMID: 36601055 Free PMC article. Review.
Next to Alzheimer's disease, Parkinson's disease constitutes the second most widespread neurological disorder, primarily affecting the older population. ...Supplementation with vitamin D can retard the aggravation of non-motor as well as motor symptoms of Parkinson' …
Next to Alzheimer's disease, Parkinson's disease constitutes the second most widespread neurological disorder, primarily affec …
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.
Pant S, Schuler M, Iyer G, Witt O, Doi T, Qin S, Tabernero J, Reardon DA, Massard C, Minchom A, Lugowska I, Carranza O, Arnold D, Gutierrez M, Winter H, Stuyckens K, Crow L, Najmi S, Hammond C, Thomas S, Santiago-Walker A, Triantos S, Sweiti H, Loriot Y; RAGNAR Investigators. Pant S, et al. Lancet Oncol. 2023 Aug;24(8):925-935. doi: 10.1016/S1470-2045(23)00275-9. Lancet Oncol. 2023. PMID: 37541273 Clinical Trial.
Association between insulin and Nrf2 signalling pathway in Alzheimer's disease: A molecular landscape.
Rahman SO, Khan T, Iqubal A, Agarwal S, Akhtar M, Parvez S, Shah ZA, Najmi AK. Rahman SO, et al. Life Sci. 2023 Sep 1;328:121899. doi: 10.1016/j.lfs.2023.121899. Epub 2023 Jun 30. Life Sci. 2023. PMID: 37394097 Review.
Suzanne de La Monte and her team reported that insulin might be involved in the pathogenesis of Alzheimer's Disease (AD) and thus coined a term "Type-3 diabetes" This hypothesis was supported by several subsequent studies. ...
Suzanne de La Monte and her team reported that insulin might be involved in the pathogenesis of Alzheimer's Disease (AD) and thus coi …
249 results